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ABSTRAK 
SAEPULLOH, M. 2004. Karakterisasi molekuler isolat virus infectious laryngotracheitis (ILTV) yang berasal dari wabah penyakit 
di daerah Lipa, Propinsi Batangas, Filipina. JITV 9(1): 26-36. 
Penelitian ini bertujuan untuk mengetahui karakter molekuler isolat virus infectious laryngotracheitis (ILT) yang berasal dari 
peternakan ayam petelur komersial di daerah Lipa, Propinsi Batangas, Filipina dengan menggunakan teknik Western blotting. 
Virus ILT diisolasi pada selaput korio allantoik (CAM) telur ayam bertunas. Lima isolat (#IV, #VI-C28, #VI-C29, #VI-C30, dan 
#VII) menghasilkan lesi berupa plak yang berwarna kekuning-kuningan di permukaan CAM pada pasase kedua. Lebih lanjut, 
kelima isolat virus tersebut dikarakterisasi dengan menggunakan teknik Western blotting dengan konsentrasi akrilamid 7,5%. 
Hasil karakterisasi menunjukkan bahwa antisera ILTV standar (NS-175) yang diproduksi pada ayam dan antisera ILTV galur 
vaksin yang diproduksi pada kelinci bereaksi dengan isolat #VI-28, #VI-29, #VI-30 dan #VII menghasilkan 4 protein virus 
utama dengan berat molekul 205, 160, 85 dan 60 kDa. Sementara itu, isolat # IV hanya menghasilkan 2 protein virus utama, 
yaitu 205 dan 85 kDa. Dengan dikenalnya keempat protein ILTV oleh kedua antisera ILT, menunjukkan bahwa telah terjadi 
reaksi silang antara protein virus asal galur vaksin dan isolat lokal yang berasal dari kota Lipa, Provinsi Batangas, Filipina. 
Terjadinya reaksi silang ini akan menjelaskan lebih lanjut bahwa pemakaian galur vaksin di lapangan akan memberikan proteksi 
yang baik pada unggas. 
Kata kunci: Infectious Laryngotracheitis, CAM, western blotting, ayam 
ABSTRACT 
SAEPULLOH, M. 2004. Molecular characterization of infectious laryngotracheitis virus (ILTV) isolates from outbreak cases at 
Lipa City, Batangas Province, The Philippines. JITV 9(1): 26-36. 
Investigations were carried out to identify molecular character of infectious laryngotracheitis virus (ILTV) isolates from 
commercial layer chicken farm located at Lipa City, Batangas Province, the Philippines using western blotting. The virus was 
first isolated in chorio allantoic membrane (CAM). A-total of five isolates (#IV, #VI-C28, #VI-C29, #VI-C30, and #VII) 
produced typical plaque lesions in CAM at second passages such as yellowish plaques with opaque edges. Furthermore, five 
isolates were then characterized by western blotting on 7.5% of acrylamide. These results showed that Chicken antisera to the 
ILTV strain NS-175 (as standard sera), and rabbit antisera to vaccine strain (BAL-ILT) recognized four major viral protein with 
molecular weight of 205, 160, 85 and 60 kDa of isolates #VI-C28, #VI-C29, #VI-30 and #VII. While the isolate # IV produced 
viral protein of 205 and 85 kDa. The same four viral proteins were recognized by both ILTV antisera, indicating that the viral 
proteins of the vaccine strain and ILTV local isolates from Lipa City, Batangas Province, the Philippine had cross-reactivity. 
Thus, this cross reactivity may cause the effective protection afforded by the vaccine strain in the field. 
Key words: Infectious laryngotracheitis virus, CAM, western blotting, chicken 
INTRODUCTION 
Infectious laryngotracheitis virus (ILTV) is a herpes 
virus belonging to the Alphaherpesvirinae subfamily. 
The virus classified as Gallid herpesvirus 1 (ROIZMAN, 
1982), causes an acute disease of chickens characterized 
by respiratory depression, gasping, and expectoration of 
blood exudates (ABBAS and ANDREASEN, 1996). Strains 
of ILTV vary considerably in their virulence (HANSON 
and BAGUST, 1991). The disease is found worldwide 
and sporadic outbreaks occur in which the severity of 
clinical symptoms may vary considerably. RAMOS et al. 
(1980) reported that a milder form of infectious 
laryngotracheitis has become widespread in Rizal 
Province. In the recent years, a milder form of ILT was 
also found in commercial layer chicken farm at district 
of Bogor, Bekasi and Tangerang, West Java, Indonesia 
in 2000 (SAEPULLOH et al., 2003) and in Lipa City, 
Batangas Province, Philippines in 2003 (SAEPULLOH 
and ROVIRA, 2003). Although the local isolates of ILT 
virus from field cases has already been isolated, but 
molecular characterization of those isolates have not 
been reported yet both in the Philippines and also in 
Indonesia. 
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Although minor antigenic variation has been 
reported among isolates of ILTV, virus neutralization 
(VN) and immuno-fluorescence performed with 
polyclonal antibodies have shown most strains to be 
antigenically homogenous even though they vary in 
virulence (ABBAS and ANDREASEN, 1996). 
YORK et al. (1987) showed that chicken anti-sera to 
ILT vaccine strain (SA-2) and to a virulent isolates 
immuno-precipitated five major viral glycoproteins of 
205, 160, 115, 90 and 60 kiloDaltons (kDa), 
respectively. An additional glycoprotein bands are 
recognized by immune chicken and rabbit sera in 
Western blotting using glycoprotein fraction purified 
from extract of virus infected cells. WATARI et al. 
(1987) reported that the envelope glycoproteins of 
herpesvirus, which are located both on the outside of 
the virus and on the surface of the virus-infected cells, 
are important immunogens capable of inducing humoral 
and cellular immune response. The possible 
involvement of other virion components in the immune 
response has not yet been investigated (YORK et al., 
1987).  
Further work using monoclonal antibodies defined 
the five major glycoproteins into two groups: the 205 
complex (205, 160, 115 and 90 kDa glycoprotein) and 
the 60 kDa glycoproteins (YORK and FAHEY, 1990). 
YORK et al., (1987) reported that immune chicken 
serum and serum from rabbits hyperimmunized either 
with whole virus or with a glycoprotein fraction gave 
essentially the same profile in Western blotting, 
indicating that the ILTV glycoproteins are both highly 
antigenic and immunogenic. 
The objective of this research was to identity 
molecular character of five ILTV local isolates from 
Batangas compare with vaccine strain (ILT-BAL, 
Singapore) using western blotting technique. 
MATERIALS AND METHODS 
Isolates 
Five ILTV isolates from field cases in Lipa City, 
Batangas, the Philippines were propagated in chorio 
allantoic membrane (CAMs) of 10-12 day-old 
embryonated chicken eggs. All of isolates showed 
typical pocks lesion in CAMs such as whitish or 
yellowish pocks with opaque edges, depressed gray 
central area of necrosis, and small pocks on CAMs, 
which were frequently surrounded by a translucent 
edematous zone. 
Antigen 
A commercial attenuated live ILT virus vaccine 
(BAL-ILT) from BESTAR Laboratories, Singapore was 
propagated in 10-12 day-old embryonated chicken eggs. 
The ILTV antigen was prepared essentially according to 
the methods described by IZUCHI et al. (1982). Briefly, 
the virus was propagated in embryonated chicken eggs. 
For our purposes, this antigen was further propagated 
by inoculation, incubated at 37°C and observed for dead 
embryos for 6 days. The embryos died on the first day 
of inoculation were discarded, and embryos died on 2 to 
6 days post-inoculation were chilled at 4°C for 24 hour. 
The CAM of embryonated eggs were then examined for 
typical pock lesions. The infected CAMs were 
grounded and made 10% suspension in Dulbeco’s 
Modified Eagle Medium, DMEM (GIBCO). A 10% of 
CAM suspension was clarified at 1,600 x g for 15 min 
at 4°C, and the supernatant was tested using rapid HA. 
The supernatant that gave a negative HA reaction was 
used as ILT antigen and stored at –80 °C until used.  
Positive and negative serum standard reference 
Hyperimmune sera against ILTV strain NS-175 
(Japanese standard reference strain) was obtained from 
Dr. Osamu ITOH (National Veterinary Assay 
Laboratory, Tokyo, Japan) and from Dr. Ida Lestari 
Soedidjar (Veterinary Drug Assay Laboratory, Bogor, 
Indonesia). These sera were produced in Specific 
Pathogen Free (SPF) of chickens. Negative control sera 
prepared in SPF of chicken were also provided by the 
above individuals. 
Production of rabbit hyperimmune sera against ILT 
virus 
Hyperimmune sera were prepared for each ILTV 
isolate in order to determine cross reactivity among the 
various isolates and the vaccine virus as well. The ILTV 
vaccine virus (BAL-ILT, Bestar, Singapore) and five 
ILTV local isolates were grown in CAMs of 
embryonated chicken egg and were passaged up to the 
5th embryo-passage. The virus was titrated using 
method of GELENEZEI and MARTY (1964) and 
calculated using the method of REED and MUENCH 
(1938). 
A-crude ILTV isolate and the vaccine strain 
containing of log 104.3 EID50/ml was used for 
inoculation into each New Zealand white rabbits. 
Another rabbit was injected with CAM suspension 
(serve the negative sera as control). Virus was first 
inactivated using beta-propiolactone at final 
concentration of 0.2% (v/v) (FAHEY et al., 1983). The 
viability of this virus was then tested using the egg 
inoculation test, and immunologic capability was 
determined using the AGID. Inactivated ILT virus was 
then emulsified in an equal volume of Freund’s 
Complete Adjuvant, FCA (SIGMA) and was injected 1 
ml subcutaneously into rabbits. Booster was given 2 
weeks later by 1 ml crude virus suspensions 
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intravenously. Three weeks later, the rabbit was 
inoculated by the same isolate intravenously at weekly 
interval. Each rabbit was bled at 2, 3 and 4 weeks post 
immunization for the detection of titer antibody. On the 
fifth week, the rabbits were bled and sacrificed. The 
collected blood was processed in order to separate 
serum from other blood components. A total of seven 
different hyperimmune sera were obtained from seven 
rabbits. Antibody titers of the sera collected were 
determined using the AGID test.  Sera produced from 
one virus isolate containing 1:16 antibody titer was 
pooled. 
Concentration and purification of infectious 
laryngotracheitis (ILT) virus 
The concentration and purification procedures used 
for the five ILTV local isolates and vaccine strain was 
modifications of protocols reported by SCHLOER and 
BREESE (1982). Infected CAMs were ground to make 
crude virus preparations for each ILTV isolate and 
vaccine strain. In order to concentrate the virus in the 
suspension, Polyethylene Glycol (PEG #8000) and 
NaCl were added to make 8 and 3% (w/v) solution, 
respectively. These suspensions were centrifuged at 
3,000 rpm for 1 hour. The pellets were collected and re-
suspended with 1/10 volume in Tris-Saline Buffer 
(TSB) pH 7.4. Purified virus was separated from the 
rest of the cell debris through 20-60% sucrose-density 
gradient. Single band formation was achieved by 
200,000 x g for 5 hours (SW 28 rotor, Beckman). The 
bands were individually collected and dialyzed in PBS 
for 12 hours at 4°C to remove the sucrose. The protein 
contents were determined by spectrophotometric 
reading at 280 nm. Results of the readings were 
recorded. These readings were eventually used for 
adjusting protein concentrations in subsequent SDS-
PAGE studies.  
SDS-PAGE of protein  
Sodium Dodecyl Sulphate–Polyacrylamide Agar 
Gel Electrophoresis (SDS-PAGE) was performed using 
7.5% acrylamide resolving gel with 5% stacking gels 
using the continuous system of LAEMMLI (1970). 
Briefly, approximately 100 µg of protein was loaded 
per well. The electrophoresis, staining, and de-staining 
of the gels were performed as described by HAMES 
(1981). Briefly, gels were run with constant voltage at 
50 volts at room temperature for 2 hours, stained for 1 
hour at room temperature with 0.5% (w/v) Coomassie 
Brilliant Blue in 25% of methanol: 10% of glacial 
acetic acid and de-stained in several changes with 25% 
of methanol; 10% of glacial acetic acid. 
Western blotting  
The transfer of proteins from the separation gel to a 
membrane surface was performed as described by 
TOWBIN et al. (1979) and YORK et al. (1987) with 
modification. Briefly, protein was separated under 
reducing conditions by discontinuous polyacrylamide 
gel electrophoresis (PAGE) and transferred to a 
nitrocellulose membrane (7-cm x 10-cm, 0.45 µm, N-
8142, Lot #10B148142, SIGMA) by electrophoresis 
with constant voltage at 50 volt using a BIORAD 
Miniprotean ™ for 2 hours. The nitrocellulose from the 
electroblot apparatus was rinsed in Phosphate Buffered 
Saline (PBS) for 5 minutes, and soaked in blocking 
solution (20 mL of 5% skim milk, Amersham Life 
Science) at room temperature for 60 minutes with 
gentle agitation. The blocking solution was discarded 
and the membrane was rinsed three times in PBS (5 
minutes/rinse). Optimization of antibody concentration 
was performed using the following dilutions: 1:10, 
1:100, 1:200 and 1: 400, respectively. 
The membrane was then incubated in 10 mL of 
polyclonal antibody standard against ILTV as primary 
antibody (1:100 in 1% of gelatin) for 5 hours at 37°C 
while gently shaking. The membrane was rinsed twice 
in Tween 20-PBS (TPBS) and once in PBS only, 5 
minutes each rinse. The blots were incubated with 
secondary Rabbit anti-Chicken IgG horseradish 
peroxidase (HRP) labeled antibody conjugate 
(SIGMA). Conjugate dilution was also optimized from 
1:100 to 1:1000 dilutions. Further test used a diluted 
1:500 conjugate in 1% gelatin for 2 hours at 37°C while 
gently shaking. The membrane was again rinsed twice 
in TPBS and once in PBS, 5 minutes each rinse, and 
treated with 3,3’ Diaminobenzidine (DAB) substrate 
(Roche Diagnostic GmbH, Germany) until dark 
brown/black color developed. Typical incubations were 
from 5 to 15 minutes. The SDS-PAGE high range 
standards (49 to 205 kDa) (SIGMA) was used as 
molecular weight standard.  
RESULTS 
Hyperimmune production and antibody titers 
Rabbit antiserum titers against ILTV were 
determined using the AGID test. The immunization 
program had 6 bleeds at the follow dates: day 0, 14, 21, 
28, 35 and 42. At day zero, none of the rabbits gave 
positive precipitation lines in the AGID test and can be 
considered to have no prior exposure to the ILT virus. 
These rabbits were unrelated to each other and were 
obtained from various sources in Lipa City, Batangas. 
Their response to this immunization protocol was 
varied as can be demonstrated in Table 1. 
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Tabel 1. Detection of antibody titers of rabbits immunized against ILT at various points in the immunization schedule using the 
AGID test 
Titer of virus (Au*) 
Virus Rabbit No. 
Day 0 Day 14 Day 21 Day 28 Day 35 Day 42 
Vaccine strain 1 0 0 4 16 16 16 
Isolate # IV 2 0 0 2 4 2 1 
Isolate # VI-C28 3 0 0 4 4 4 4 
Isolate # VI-C29 4 0 0 4 16 4 4 
Isolate # VI-C30 5 0 0 8 16 16 4 
Isolate # VII-7 6 0 0 2 16 16 4 
Uninfected CAM 7 0 0 0 0 0 0 
*AGID Unit 
The rabbits inoculated with the vaccine strain, 
isolate # VI-C29, isolate # VI-C30, and isolate # VII-7 
did not show an antibody response after the 7th and the 
14th day of the immunization period. It was possible that 
the antibody levels mounted by these animals during 
this period were low and not detected by the AGID test. 
Since the animals used in this study have no previous 
exposure to the antigen, it was expected that they will 
take several days to mount up a good antibody 
response.  
Concentration and purification of infectious 
laryngotracheitis (ILT) virus 
The result of concentration and purification to all of 
five ILTV local isolates demonstrated that purified 
ILTV had a single band around the middle of the tubes 
(Figure 1). The vaccine virus strain similarly had the 
same band location as the isolates. This indicated that 
all of virus isolates as well as the vaccine positive 
control had the same buoyant density (1.704 g/mL). The 
protein contents were determined by 
spectrophotometric reading at 280 nm. Results of the 
readings were recorded in Table 2. These readings were 
eventually used for adjusting protein concentrations in 
subsequent SDS-PAGE studies.  
The results of the spectrophotometric readings 
showed that the vaccine strain had the highest protein 
content at 0.7400 mg/mL. Concentration of the ILTV 
isolates from highest to lowest were # VI-C28 at 0.6486 
mg/mL, isolate #VI-C30 at 0.5871 mg/mL, isolate # IV 
at 0.5142 mg/mL, isolate # VI-C29 at 0.4421 mg/mL 
and isolate #VII-7 at 0.1807 mg/mL. All ILTV isolates 
had the right concentration necessary for SDS-PAGE 
studies. These studies require a concentration of 0.5 to 5 
µg per lane (20µL) in order for the protein to be 
detected by coomassie blue staining (WILSON, 1983). 
 
Figure 1. Purification ILTV by sucrose gradient centrifugation. 
A single band was obtained by density gradient 
centrifugation in 20-60% sucrose, centrifugation 
200,000 x g for 5 hours at 4°C 
Sodium dodecyl sulphate – polyacrylamide gel 
electrophoresis (SDS-PAGE) 
The presence of ILTV specific proteins was 
determined by SDS-PAGE using 7.5% acrylamide gel. 
Major protein bands were identified and these migrated 
at the following molecular weights: 205, 160, 85 and 60 
kDa. The banding patterns, however differed slightly 
among the isolates and vaccine strain. Table 3 and 
Figure 2, summarizes the protein profile of the vaccine 
strain and each of the five field isolates. These results 
revealed that the common band at 85 kDa in all isolates 
as well as the vaccine strain. Isolates # VI-C28, # VI-
C29, #VI-C30 and #VII had the same banding patterns, 
which included all four major proteins: 205, 160, 85 
and 60 kDa. In contrast, isolate # IV had only two 
major bands and lacked of protein bands 160 kDa and 
60 kDa. In comparison, the banding profile of the 
vaccine strain virus showed the lack of protein band 
205 kDa.  
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Tabel 2. Protein content of ILT virus after sucrose gradient (20-60%) purification 
Protein content 
Virus Absorbance reading at 280 nm 
mg/mL µg/20 µL 
Vaccine strain 1.036 0.7400 14.80 
Isolate # VI-C28 0.908 0.6486 12.97 
Isolate # VI-C29 0.616 0.4421 8.84 
Isolate # VI-C30 0.822 0.5871 11.74 
Isolate # IV 0.720 0.5142 10.28 
Isolate # VII-7 0.253 0.1807 3.61 
Tabel 3. Protein profile of purified ILTV isolates from Batangas and vaccine strains analyzed by SDS-PAGE on 7.5% gel 
Proteins (kDa) 
Virus 
205 160 85 60 
Isolate #IV + - + - 
Isolate #VI-C28 + + + + 
Isolate #VI-C29 + + + + 
Isolate #VI-C30 + + + + 
Isolate #VII + + + + 
Vaccine ILT-BAL - + + + 
 
MW = molecular weight standard, 1) Purified CAMs (negative control), 2) isolate from Farm # IV, 3) isolate from 
Farm VI # C28, 4) isolate from Farm VI # C29, 5) isolate from Farm VI # C30, 6) isolate from farm VII #7 and 7) 
vaccine ILT-BAL (positive control) 
Figure 2. Purified of ILTV isolates from the Philippines and vaccine strains analyzed by SDS-PAGE on 7.5% gel 
Western blotting 
Optimization of primary and secondary antibody 
In order to minimize the background and increase 
specificity, the primary antibody (polyclonal antibody) 
concentration was optimized. Optimization experiments 
were performed using the ILTV vaccine virus as 
antigen, and the rabbit anti-ILTV raised against the 
vaccine virus as primary antibody. The result 
demonstrated that the optimum conditions determined 
for both primary antibody and the rabbit anti-chicken 
IgG-HRP conjugate were 1:100 and 1:500, respectively. 
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Characterization of ILT specific viral protein present 
in virus-infected cells 
The ILT viral proteins demonstrated by SDS-PAGE 
were reacted to antibodies that were produced against 
the crude form of the virus. Assessment of this reaction 
was through western blotting using purified isolates # 
IV, #VI-C28, #VI-29, #VI-C30, #VII and vaccine strain 
as antigen. The viral proteins were separated by SDS-
PAGE, transferred to nitrocellulose, and probed with 
rabbit anti-sera against isolate #IV, isolate #VI-C28, 
isolate #VI-29, isolate #VI-C30, isolate #VII, ILT 
vaccine strain and chicken anti-sera to ILTV strain NS-
175. 
Major protein bands recognized by the anti NS-175 
sera (Table 4). The specific viral proteins 250, 160, 85, 
and 60 kDa of isolates #VI-C28, #VI-C29, #VI-C30, 
and #VII were all recognized. Although raised using a 
different strain, the anti-ILTV NS-175 sera also 
immunologically recognized protein bands 205 and 85 
kDa of isolate #IV and all three proteins bands (160, 85 
and 60 kDa) of the ILTV vaccine. 
Purified isolates # IV, #VI-C28, #VI-29, #VI-C30, 
#VII and vaccine strain were reacted with rabbit anti-
sera to raised against isolate # IV (Table 5). From the 
SDS-PAGE results, isolate # IV demonstrated only two 
major protein bands despite this, however, the rabbit 
anti-sera against isolates # IV recognized all the specific 
viral proteins of 205, 160, 85 and 60 kDa from viral 
isolates #VI-C28, #VI-C29, #VI-C30 and #VII. Only 
viral proteins of 160, 85 and 60 kDa from the ILT 
vaccine can be recognized by anti-isolate #IV. Anti-
isolate #IV against its homologous protein recognized 
both 205 and 85 kDa proteins of the isolate. Despite the 
absence of bands 205 and 60 kDa in the SDS-PAGE 
protein profiles of isolate #IV, the anti-sera produced 
against this virus recognized these bands in the other 
isolates (#VI-C28, #VI-C29, #VI-C30 and #VII) and in 
the vaccine virus strain as well. 
Immunological recognition of ILTV Batangas 
isolates and ILTV vaccine against anti-isolate #VI-C28 
revealed four major consistent bands with the following 
molecular sizes (kDa): 205, 160, 85 and 60 in ILTV 
isolates # VI-C28, #VI-C29, #VI-30 and #VII (Table 6). 
The protein bands of isolates #VI-C29, #VI-30 and 
#VII were also recognized but with a lesser degree of 
intensity relative to the homologous strain. Reaction
Table 4. Immunologic recognition of ILTV Batangas isolates and ILTV vaccine virus against anti-serum standard (anti-ILTV 
strain NS-175) in Western Blot 
Proteins (kDa) 
Virus 
205 160 85 60 
Isolate #IV + No Band* + No Band* 
Isolate #VI-C28 + + + + 
Isolate #VI-C29 + + + + 
Isolate #VI-C30 + + + + 
Isolate #VII + + + + 
Vaccine ILT-BAL No Band* + + + 
* No protein band demonstrated in SDS-PAGE gels 
Table 5. Immunologic recognition of ILTV Batangas isolates and ILTV vaccine virus against anti-isolate #IV in Western Blot 
Proteins (kDa) 
Virus 
205 160 85 60 
Isolate #IV + No Band* + No Band* 
Isolate #VI-C28 + + + + 
Isolate #VI-C29 + + + + 
Isolate #VI-C30 + + + + 
Isolate #VII + + + + 
Vaccine ILT-BAL No Band* + + + 
* No protein band demonstrated in SDS-PAGE gels 
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was less especially to the 85-kDa protein. The ILT 
vaccine has three major protein bands (160, 85 and 60 
kDa), were also identified clearly. The anti- #VI-C28 
hyperimmune sera recognized only one of the major 
protein (85kDa) of isolate #IV. The reaction to this 
protein band was very weak compared to the other band 
reactions.  
Hyperimmune sera against isolate #VI-C29 
similarly recognized all four major protein of isolates 
#VI-C28, #VI-C29, #VI-C30, and #VII with molecular 
weight of 205, 160, 85 and 60 kDa (Table 7). Unlike the 
previous blots described above, anti - #VI-C29 sera, 
recognized the bands of isolates #VI-C28, #VI-C30, 
and #VII with the same intensity as the homologous 
strain. The anti-isolate # VI-C29 anti-sera recognized 
both proteins of isolate #IV (MW 205 and 85 kDa). 
Hyperimmune sera against isolate # VI-C30 
similarly recognized all four major protein of isolates 
#VI-C28, #VI-C29, #VI-C30, and #VII with molecular 
weighs of 205, 160, 85 and 60 kDa (Table 8). Unlike 
the previous blots described above, anti-#VI-C30 sera, 
recognized the bands of isolates #VI-C28, #VI-C29, 
and #VII with the same intensity as the homologous 
strain. The anti-isolate #VI-30 recognized both proteins 
of isolate #IV (MW 205 and 85 kDa). Recognition of 
the 85-kDa protein was seen, however, the reaction for 
205-kDa was recognizably less. In the vaccine strain, all 
proteins were recognized sharply. 
Similarly, hyperimmune sera against isolate #VII 
recognized all four major proteins of isolates #VI-C28, 
#VI-C29, #VI-C30 and homologous antigen, #VII with 
molecular weighs of 205, 160, 85 and 60 kDa (Table 9).  
Unlike the previous blots described above, anti-#VII 
sera, recognized the bands of isolates #VI-C28, #VI-
C29, and #VI-30 with the same intensity as the 
homologous strain. The anti-isolate #VII anti-sera 
recognized both proteins of isolate #IV (MW 205 and 
85-kDa). Most distinct was the strong reaction for the 
85-kDa protein. The reaction for the 205-kDa, however, 
was recognizably less. All proteins in the vaccine strain 
were recognized sharply. 
The hyperimmune sera against ILT vaccine virus 
strain recognized three major protein bands (160, 85 
and 60 kDa) of isolates #VI-C28, #VI-C29, #VI-C30, 
#VII (Table 10) and all bands of the homologous 
vaccine antigen. The recognition of the bands in 
isolates, #VI-C28, #VI-C29, #VI-C30 and #VII were of 
similar intensity as the homologous strain. The anti-
vaccine strain anti-sera only recognized one protein of 
isolate #IV, the 85-kDa protein. Interestingly, this 
hyperimmune serum did not recognize protein band 205 
kDa, which is only present in the field isolates.  Unlike 
the field strains, this protein band was absent in the 
SDS-PAGE profile of the vaccine strain virus.  
Therefore, the immunized rabbit against protein 205 
kDa formed no antibodies. 
Table 6. Immunologic recognition of ILTV Batangas isolates and ILTV vaccine virus against anti-isolate #VI-C28 in Western 
Blot 
Proteins (kDa) 
Virus 205 160 85 60 
Isolate #IV No Rxn^ No Band* + No Band* 
Isolate #VI-C28 + + + + 
Isolate #VI-C29 + + + + 
Isolate #VI-C30 + + + + 
Isolate #VII + + + + 
Vaccine ILT-BAL No Band* + + + 
* No protein band demonstrated in SDS-PAGE gels 
^ No reaction in this Western Blot 
Table 7. Immunologic recognition of ILTV Batangas isolates and ILTV vaccine virus against anti-isolate #VI-C29 in Western 
Blot 
Proteins (kDa) 
Virus 205 160 85 60 
Isolate #IV + No Band* + No Band* 
Isolate #VI-C28 + + + + 
Isolate #VI-C29 + + + + 
Isolate #VI-C30 + + + + 
Isolate #VII + + + + 
Vaccine ILT-BAL No Band* + + + 
* No protein band demonstrated in SDS-PAGE gels 
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Table 8. Immunologic recognition of ILTV Batangas isolates and ILTV vaccine virus against anti-isolate #VI-C30 in Western 
Blot 
Proteins (kDa) 
Virus 
205 160 85 60 
Isolate #IV + (weak) No Band * + No Band* 
Isolate #VI-C28 + + + + 
Isolate #VI-C29 + + + + 
Isolate #VI-C30 + + + + 
Isolate #VII + + + + 
Vaccine ILT-BAL No Band* + + + 
* No protein band demonstrated in SDS-PAGE gels 
Table 9. Immunologic recognition of ILTV Batangas isolates and ILTV vaccine virus against anti-isolate #VII in Western Blot 
Proteins (kDa) 
Virus 
205 160 85 60 
Isolate #IV + (weak) No Band* + No Band* 
Isolate #VI-C28 + + + + 
Isolate #VI-C29 + + + + 
Isolate #VI-C30 + + + + 
Isolate #VII + + + + 
Vaccine ILT-BAL No Band* + + + 
* No protein band demonstrated in SDS-PAGE gels 
Table 10. Immunologic recognition of ILTV Batangas isolates and ILTV vaccine virus against anti-ILT vaccine in Western Blot 
Proteins (kDa) 
Virus 
205 160 85 60 
Isolate #IV No Band^ No Band* + No Band* 
Isolate #VI-C28 No Band^ + + + 
Isolate #VI-C29 No Band^ + + + 
Isolate #VI-C30 No Band^ + + + 
Isolate #VII No Band^ + + + 
Vaccine ILT-BAL No Band* + + + 
 * No protein band demonstrated in SDS-PAGE gels 
 ^ Protein band not reacted by antibodies in anti- Vaccine ILT-BAL 
DISCUSSION AND CONCLUSION 
In order to produce hyperimmune sera, at the 
highest antibody titers were produced after the third 
injection (21-days), and blood was collected at 7 days 
after immunization. The data showed that the rabbits 
inoculated with the vaccine strain, isolate # VI-C29, 
isolate # VI-C30 and isolate # VII-7 produced high 
titers that reached 16 AU (AGID unit). Meanwhile, the 
rabbits inoculated with isolate #IV and isolate # VI-C28 
produced moderate titers (4 AU) at 21 days.  
On the 5th week (35 days), only rabbits inoculated 
with the vaccine strain, isolate #VI-C30 and isolate # 
VII-7 maintained a high titer (16 AU) and the rabbits 
inoculated with isolate #VI-C29 decreased in titer (4 
AU). On the other hand, the rabbit immunized with 
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isolate #VI-C28 maintained the titer of 4 AU.  Antibody 
titers of the rabbit inoculated with isolate # IV were 
very low titer, but detectable at 2 AU. The rabbit 
inoculated with CAM suspension induced no detectable 
antibody in the duration of this experiment. 
At 35th days onward, antibody titers dropped, except 
for the rabbit inoculated with the vaccine strain. This 
rabbit maintained high levels of antibody titer (16 AU) 
until the 42nd day. It was unfortunate that the rabbit 
inoculated with isolate # IV dropped to an antibody titer 
of 1AU. Each bleed that tested 4 AU and above were 
pooled for each animal and used for western blotting 
since this test require large volume of hyperimmune 
serum. The control negative anti-sera were none 
reactive to the ILT antigen through the whole duration 
of the test. All animals were bled and sacrificed on the 
6th week (42 days) of the immunization schedule. 
Differences in antibody titers may be due to the 
rabbits used for hyperimmune production. There are 2 
rabbits that injected with isolate #IV and #VI-C28 
showed scabies symptoms after 2 weeks post 
immunization (data not shown). Thus, they are not only 
lack of drink and eat but also loss of body weight. This 
condition could affect the antibody responses 
demonstrated.  
Previous works on ILTV characterization vary in 
their reports of number of protein bands demonstrated 
in SDS-PAGE. YORK et al. (1987) reported that ILTV 
propagated in primary chicken kidney (CK) cells have 6 
major proteins of 205, 160, 115, 90, 85, and 60 kDa. 
ABBAS and ANDREASEN (1996), however, reported that 
the ILTV grown in chicken embryo liver cells have 5 
major proteins of 205, 160, 100, 90 and 70 kDa. This 
study used the ILTV propagated in chorio allantoic 
membrane (CAM) and demonstrated 4 major proteins 
of 205, 160, 85 and 60 kDa.  
Differences in such findings could be due to 3 
factors. The factors are: (1) it could be occur because 
the antibody recognizes a determinant that is common 
to more than one polypeptide. Alternatively, the smaller 
proteins could be cleavage products of larger proteins 
and could be related by precursor–product relationships, 
or could represent forms of the protein which are 
glycosylated differently. Similar phenomenon has been 
observed for many monoclonal antibody directed 
against herpesvirus antigens (PEREIRA et al., 1984; 
COLLINS et al., 1984; and HAMPL et al., 1984); (2) The 
differences in the cells used for virus propagation.  
Being an enveloped virus, ILTV contains various 
components from its host cells. This includes lipid 
bilayer, glycoproteins and protein, all of which play a 
great role in the virus structure; and (3) Differences in 
the protein extracting process applied. Several authors 
working with viruses under the family Herpesviridae 
used various detergents to extract the viral proteins. 
YORK et al. (1987), and SPEAR and ROIZMAN (1972) 
used Nonidet P-40 (NP-40) as detergent to breakdown 
the viral proteins in the infected cell. ABBAS and 
ANDREASEN (1996) similarly used NP-40 in extracting 
the ILTV in infected chicken embryo liver cells. These 
authors added tunicamycin to NP-40 prior to analyses in 
SDS-PAGE. The rationale behind the use of 
tunicamycin was the claim that this reagent can prevent 
degradation of protein. DOLYNIUK et al. (1976) in their 
study of the Eptstein Barr virus, used Phenyl-methyl-
sulfonyl-fluoride (PMSF), an anti-protease, to prevent 
breakdown of virus by cell-associated proteases. 
OLSHEVSKY and BECKER’S (1970) study on the Herpes 
simplex virus recommended that non-ionogenic 
detergent NP-40 followed by sonic treatment (1.5 A), 
for 1.5 min in the ultrasonic vibrator should be used in 
order to study the nature of the proteins present in the 
virus enveloped. 
This study did not use any extraction detergent and 
neither was anti-proteases added to the sample. The 
only protein dissolving detergent present was sodium 
dodecyl sulfate, a reagent in the sample buffer and the 
acrylamide gel. The focus of this work was to maintain 
as much as possible the native state of the proteins. The 
preservation of immunologic characteristics of viral 
surface proteins was essential in order to demonstrate 
their reaction with antibodies. Certain detergents act on 
various proteins bands, thus breaking them into smaller 
peptides. Mild detergents may also change tertiary 
structures, thus results to none recognition by antibody. 
Compared to the previous works on ILT proteins, this 
study report the least number of proteins band, four 
major proteins. This could be due to the absence of 
detergents in the extraction process. The proteins 
demonstrated were of same molecular weights of 
proteins reported by YORK et al. (1987). The interesting 
of this study was limited to proteins located on the 
envelope of the virus and not those in the core, capsid 
or tegument. Maintenance of proteins in their native 
state was the goal of the study, thus use of detergent 
was limited. Sodium dodecyl sulfate was the only 
detergent present. Its mechanism of action is focused 
only on the sulfide bonds. Slightly denaturalization of 
protein conformation was expected, however, the size 
of the protein would still be the same as in its native 
state.  
There were two kinds of primary polyclonal 
antibodies were used for ILTV characterization. One of 
the primary antibodies used was from SPF chickens, 
immunized against ILTV strain NS-175, while the other 
primary antibody used was from rabbits, immunized 
against ILTV suspected isolates from Batangas as well 
as the ILTV vaccine strain. One secondary antibody 
used for detection of both primary antibodies. This was 
produced in rabbits immunized against anti-chicken 
IgG.  It was a commercial preparation (SIGMA) and the 
antibodies were conjugated to horseradish peroxidase 
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(HRP). As seen in the immunoblot reactions, both of 
chicken and rabbit antibodies were detected by the 
secondary rabbit anti-chicken IgG peroxidase 
conjugated. Similarly, YORK et al. (1987) reported 
western blot detection of viral proteins 205, 160, 115, 
90, 85, 70 and 60 kDa. The secondary antibody, a rabbit 
anti-chicken IgG by Cappel Laboratories (Cochranville, 
PA), was used to detect rabbit anti-ILTV antibodies. 
Some of the proteins detected in YORK et al. (1987) 
study, coincided with the molecular weights of the 
proteins demonstrated in this experiment, namely, the 
205, 160, 85 and 60 kDa proteins. The western blot 
protocols followed were similar to that used in this 
work. Although anti-chicken conjugated antibodies 
were used to detect rabbit antibodies, this did not hinder 
the detection of major ILT viral proteins in both studies. 
TIZARD (2002) explained that evolutionary relationships 
among the major of vertebrate immunoglobulin heavy 
chain could have been preserved over time. One 
example is the Cα gene of the chicken, which is found 
to be similar to their homolog in mammals such as 
rabbits, mouse and gorilla. This probably explains why 
the rabbit anti-chicken conjugate by SIGMA and 
CAPPEL laboratories reacted with the rabbit anti-ILTV 
antibodies. Later immunoblot studies by ABBAS et al. 
(1996) on their ILT virus isolates involved the use of 
monoclonal antibodies. Proteins 205, 160, 100, 90, and 
70 kDa and several proteins less than 49 kDa were 
detected. Monoclonal antibodies were used as primary 
antibody and were detected by a goat anti-mouse 
peroxidase labelled antibody (Hyclone Laboratories 
Inc., Logan, Utah). Similarity of detection of 205 and 
160 kDa proteins were seen here. Differences in the 
proteins detected may be caused by differences in the 
protein extraction method using NP –40 as detergent. 
The following highlights can be concluded from the 
Western blotting results of this study: (1) There are 
cross-reactivity of the viral protein of the vaccine strain 
and viral isolates of ILTV may explain the effective 
protection afforded by the vaccine strain in the field; 
and (2) Standard ILT serum (anti NS-175) and serum 
from rabbit hyperimmunized reacted with whole ILTV 
isolates gave essentially the same profile in Western 
blotting, indicating that the ILTV proteins are both 
highly antigenic and immunogenic. 
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